Literature DB >> 24338220

Adverse effects of clozapine in older patients: epidemiology, prevention and management.

Delia Bishara1, David Taylor.   

Abstract

Research into the use of clozapine in older people is somewhat scarce. Clozapine is associated with serious adverse effects such as agranulocytosis, seizures, myocarditis and metabolic syndrome. Other common undesirable effects such as sedation, constipation (which can be fatal), urinary incontinence and hypersalivation further limit its use. These adverse effects are particularly important for the use of clozapine in older people, who are generally more susceptible to medication-related adverse effects. Whilst clozapine should be used with caution in elderly people, strict monitoring procedures can help to prevent harmful effects through early detection, and certain management techniques exist to minimise them. This review outlines the epidemiology of clozapine-related adverse effects in older people and discusses potential prevention and management strategies.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 24338220     DOI: 10.1007/s40266-013-0144-2

Source DB:  PubMed          Journal:  Drugs Aging        ISSN: 1170-229X            Impact factor:   3.923


  64 in total

1.  Severe hyponatraemia associated with desmopressin nasal spray to treat clozapine-induced nocturnal enuresis.

Authors:  Shanthi Sarma; Warren Ward; Justin O'Brien; Aaron D J Frost
Journal:  Aust N Z J Psychiatry       Date:  2005-10       Impact factor: 5.744

2.  Multimorbidity in general practice: prevalence, incidence, and determinants of co-occurring chronic and recurrent diseases.

Authors:  M van den Akker; F Buntinx; J F Metsemakers; S Roos; J A Knottnerus
Journal:  J Clin Epidemiol       Date:  1998-05       Impact factor: 6.437

Review 3.  Myocarditis, pericarditis and cardiomyopathy in patients treated with clozapine.

Authors:  P M Wehmeier; P Heiser; H Remschmidt
Journal:  J Clin Pharm Ther       Date:  2005-02       Impact factor: 2.512

Review 4.  Managing bipolar disorder in the elderly: defining the role of the newer agents.

Authors:  Martha Sajatovic; Subramoniam Madhusoodanan; Nicoleta Coconcea
Journal:  Drugs Aging       Date:  2005       Impact factor: 3.923

5.  Frailty in older adults: evidence for a phenotype.

Authors:  L P Fried; C M Tangen; J Walston; A B Newman; C Hirsch; J Gottdiener; T Seeman; R Tracy; W J Kop; G Burke; M A McBurnie
Journal:  J Gerontol A Biol Sci Med Sci       Date:  2001-03       Impact factor: 6.053

6.  Clozapine for the treatment-resistant schizophrenic. A double-blind comparison with chlorpromazine.

Authors:  J Kane; G Honigfeld; J Singer; H Meltzer
Journal:  Arch Gen Psychiatry       Date:  1988-09

7.  An assessment of clinical practice of clozapine therapy for veterans.

Authors:  M Sajatovic; C R Bingham; D Garver; L F Ramirez; G Ripper; F Blow; L S Lehmann
Journal:  Psychiatr Serv       Date:  2000-05       Impact factor: 3.084

8.  Plasma clozapine and norclozapine in relation to prescribed dose and other factors in patients aged 65 years and over: data from a therapeutic drug monitoring service, 1996-2010.

Authors:  Sally Bowskill; Lewis Couchman; James Hunter MacCabe; Robert James Flanagan
Journal:  Hum Psychopharmacol       Date:  2012-03-15       Impact factor: 1.672

9.  Clozapine in the elderly.

Authors:  F R Frankenburg; D Kalunian
Journal:  J Geriatr Psychiatry Neurol       Date:  1994 Apr-Jun       Impact factor: 2.680

10.  Treatment of clozapine-induced hypersalivation with ipratropium bromide: a randomized, double-blind, placebo-controlled crossover study.

Authors:  Sanjeev Sockalingam; Chekkera Shammi; Gary Remington
Journal:  J Clin Psychiatry       Date:  2009-08       Impact factor: 4.384

View more
  4 in total

Review 1.  Safety of antipsychotics for the treatment of schizophrenia: a focus on the adverse effects of clozapine.

Authors:  Domenico De Berardis; Gabriella Rapini; Luigi Olivieri; Domenico Di Nicola; Carmine Tomasetti; Alessandro Valchera; Michele Fornaro; Fabio Di Fabio; Giampaolo Perna; Marco Di Nicola; Gianluca Serafini; Alessandro Carano; Maurizio Pompili; Federica Vellante; Laura Orsolini; Giovanni Martinotti; Massimo Di Giannantonio
Journal:  Ther Adv Drug Saf       Date:  2018-02-06

Review 2.  Treatment strategies for clozapine-induced hypotension: a systematic review.

Authors:  Timothy David Tanzer; Thomas Brouard; Samuel Dal Pra; Nicola Warren; Michael Barras; Steve Kisely; Emily Brooks; Dan Siskind
Journal:  Ther Adv Psychopharmacol       Date:  2022-05-24

Review 3.  Antipsychotic-Induced Constipation: A Review of the Pathogenesis, Clinical Diagnosis, and Treatment.

Authors:  Yue Xu; Nousayhah Amdanee; Xiangrong Zhang
Journal:  CNS Drugs       Date:  2021-08-24       Impact factor: 5.749

4.  Clozapine Patients at the Interface between Primary and Secondary Care.

Authors:  Marita Barrett; Anna Keating; Deirdre Lynch; Geraldine Scanlon; Mary Kigathi; Fidelma Corcoran; Laura J Sahm
Journal:  Pharmacy (Basel)       Date:  2018-02-26
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.